research
Drugs ‘Rushed’ into Development to Refill Pharma Pipelines Are Less Likely to Succeed
A new study led by a Carey Business School researcher shows that when a large pharmaceutical company experiences a drug trial failure and then tries to refill its pipeline by licensing a product created by another firm, such a “rushed innovation” is less...
April 22, 2020